Warning letter
A.I.G Technologies, Inc.: warning letter of Dec 5, 2017
FDA warning letter 490872 · Dallas District Office
Key facts
| Reference number | 490872 |
|---|---|
| Company | A.I.G Technologies, Inc. |
| Subject | New Drug/Misbranded |
| Issue date | Dec 5, 2017 |
| Posted date | Dec 19, 2017 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 207.21(b) |
| Inspection city | Deerfield Beach |
| Inspection ZIP | 33064 |
| Inspection start date | Sep 27, 2015 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: